Clinical Trial Update: Efficacy of Thymosin alpha1 for Severe Sepsis [NA]

View source ↗

Summary

The clinical trial evaluating thymosin alpha-1 for severe sepsis has completed; the update does not report efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Drugs mentioned

• Thymosin alpha-1 (thymosin alpha-1)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Severe Sepsis | NA | Status: COMPLETED